Becton, Dickinson:企業のM&A・事業提携・投資動向

◆英語タイトル:Becton, Dickinson - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1714
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:89
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Becton, Dickinson – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Becton, Dickinson Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Becton, Dickinson since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Becton, Dickinson ‘s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Becton, Dickinson . These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Becton, Dickinson ‘s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Becton, Dickinson and its subsidiaries since 2007.
- Information about key financial and legal advisors for Becton, Dickinson ‘s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Becton, Dickinson ’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 23
Corporate Venturing – Overview 23
Corporate Venturing – Deal reports 24
PARTNERSHIP 26
Partnership – Overview 26
Partnership – Deal reports 27
CAPITAL RAISING 47
Capital Raising – Overview 47
Capital Raising – Deal reports 48
DIVESTMENTS 68
Divestments – Overview 68
Divestments – Deal reports 69
APPENDIX 79
Contact Us 79
About MarketLine Financial Deals Database 79
Deal Definition and Methodology 81
About MarketLine 88

List of Tables
Table 1: Becton Dickinson and Co M&A volume and value trend (2014-YTD2018)
Table 2: Becton Dickinson and Co M&A activity by geography (2014-YTD2018)
Table 3: Becton Dickinson and Co corporate venturing volume and value trend (2014-YTD2018)
Table 4: Becton Dickinson and Co corporate venturing by geography (2014-YTD2018)
Table 5: Becton Dickinson and Co partnership volume and value trend (2014-YTD2018)
Table 6: Becton Dickinson and Co partnership trend by key deal type (2014-YTD2018)
Table 7: Becton Dickinson and Co capital raising volume and value trend (2014-YTD2018)
Table 8: Becton Dickinson and Co capital raising by deal type (2014-YTD2018)
Table 9: Becton Dickinson and Co divestments volume and value trend (2014-YTD2018)
Table 10: Becton Dickinson and Co divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Becton Dickinson and Co M&A volume and value trend (2014-YTD2018)
Figure 2: Becton Dickinson and Co M&A activity by geography (2014-YTD2018)
Figure 3: Becton Dickinson and Co corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Becton Dickinson and Co corporate venturing by geography (2014-YTD2018)
Figure 5: Becton Dickinson and Co partnership volume and value trend (2014-YTD2018)
Figure 6: Becton Dickinson and Co partnership trend by key deal type (2014-YTD2018)
Figure 7: Becton Dickinson and Co capital raising volume and value trend (2014-YTD2018)
Figure 8: Becton Dickinson and Co capital raising by deal type (2014-YTD2018)
Figure 9: Becton Dickinson and Co divestments volume and value trend (2014-YTD2018)
Figure 10: Becton Dickinson and Co divestments by geography (2014-YTD2018)

★海外企業調査レポート[Becton, Dickinson:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rna Diagnostics Inc:製品パイプライン分析
    Summary Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that develops medical diagnostics molecular diagnostic technologies. The company provides solutions to manage cancer and other disease states. It offers diagnostic tools used in treatment of women undergoing chemotherapy for b …
  • Ventana Medical Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • Peabody Energy Corp:企業の戦略・SWOT・財務分析
    Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Plains All American Pipeline LP (PAA):企業の財務・戦略的SWOT分析
    Plains All American Pipeline LP (PAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Xcel Energy Inc (XEL):企業の財務・戦略的SWOT分析
    Xcel Energy Inc (XEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Andersen Construction Company:企業の戦略的SWOT分析
    Andersen Construction Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Andritz AG (ANDR):企業の財務・戦略的SWOT分析
    Andritz AG (ANDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Strongbridge Biopharma plc (SBBP):企業の財務・戦略的SWOT分析
    Summary Strongbridge Biopharma Plc (Strongbridge Biopharma), formerly Cortendo Plc is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hy …
  • Adam & Company PLC:企業の戦略・SWOT・財務情報
    Adam & Company PLC - Strategy, SWOT and Corporate Finance Report Summary Adam & Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Knoll, Inc.:企業の戦略・SWOT・財務情報
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • M+W Group GmbH:企業の戦略・SWOT・財務情報
    M+W Group GmbH - Strategy, SWOT and Corporate Finance Report Summary M+W Group GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Apple Inc:企業の戦略・SWOT・財務情報
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Program for Appropriate Technology in Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other …
  • Xactware Solutions Inc:企業の戦略的SWOT分析
    Xactware Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Modern Water plc (MWG):企業の財務・戦略的SWOT分析
    Summary Modern Water Plc (Modern Water) is a clean technology company that develops and supplies water monitoring systems. The company owns, installs and operates membrane technologies, develops and supplies systems for water monitoring. Its membrane process division utilizes forward osmosis technol …
  • Koln Dusseldorfer Deutsche Rheinschiffahrt Ag
    Koln Dusseldorfer Deutsche Rheinschiffahrt Ag - Strategy, SWOT and Corporate Finance Report Summary Koln Dusseldorfer Deutsche Rheinschiffahrt Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務分析
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ausgrid-エネルギー分野:企業M&A・提携分析
    Summary Ausgrid is a state-owned electric corporation. It transmits, distributes, and retails electricity through transmission and distribution networks. The company also offers street lighting, tree trimming, combating graffiti, energy efficiency, installation and connection of small scale embedded …
  • Yamato Holdings Co Ltd (9064):企業の財務・戦略的SWOT分析
    Yamato Holdings Co Ltd (9064) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Spectrum Pharmaceuticals Inc (SPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆